MyCEI Login


HIV Remission in a Woman of Mixed Race with AML and HIV: The New York Patient


Published Date: 07/11/2022

Expiration Date: 05/17/2025

CE Credit: CME:1


Marshall J. Glesby,MD, PhD

Marshall Glesby, MD, PhD is the Associate Chief of the Division of Infectious Diseases, and Director of the Cornell HIV Clinical Trials Unit at the Weill Cornell Medical College. Dr. Glesby graduated from the Johns Hopkins University School of Medicine. He also has a Ph.D. in Clinical Investigation from the Johns Hopkins School of Hygiene and Public Health. Dr. Glesby's research is focus on metabolic complications of HIV disease. He is active in the NIH-sponsored AIDS Clinical Trials Group (ACTG). Dr. Glesby also is the Regional Clinical Director of the New York/New Jersey AIDS Education and Training Center (AETC).

Deborah Persaud,MD

Deborah Persaud, MD is an Associate Professor in the Department of Pediatrics and Director of the Fellowship Program in Pediatric Infectious Diseases at the Johns Hopkins University of School of Medicine. Her current research focuses on drug-resistant HIV reservoirs following mother-to-child HIV-transmission, the contraction and expansion of pro-viral reservoirs over time with effective HAART, virologic and immunologic markers of elite control of HIV replication through use of early HAART in children, and novel treatment strategies to facilitate elimination of HIV reservoir to achieve cure in HIV infected infants, children and youth globally.

Learning Objectives

  • Describe the barriers to HIV cure.
  • Recognize why HIV remission and cure occurred through stem cell transplantation.
  • Discuss the relevance of different assays used to measure HIV persistence and its limitations in HIV cure research.

Continuing Education Credit Information